May 17, 2022
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR will become an equal shareholder in the combined business alongside Ampersand Capital Partners. Backed by Ampersand and KKR, Alliance and DDS plan to expand the company’s geographic reach, broaden its laboratory [...]
KromaTiD Launches Pinpoint FISH™ DNA Probes
May 17, 2022
LONGMONT, Colo. -- KromaTiD a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of KromaTiD Pinpoint FISH™ Probes. This product offering expands on our 10 years of service providing high-resolution assays with superior detection, and robust data, for our client's large [...]
May 17, 2022
RENO, Nevada. – A major new installation by Bruker is enabling sustainable energy leader, US-based Dragonfly Energy, to accelerate its pioneering battery technology research with a differentiated high performance in-house research facility. Dedicated to lithium and next-generation solid-state battery optimization, the site features a range of high-tech analytical instrumentation to help drive the global conversion [...]
May 17, 2022
New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development SANTA ANA, California -- FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced [...]
May 17, 2022
Report outlines work done to date to advance priorities of Avantor's Science for Goodness sustainability platform RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today released its 2022 sustainability report highlighting the company's significant progress [...]
Forensic Laboratories Gain Unique Flexibility with Spectrum CE System
May 17, 2022
Long-anticipated instrument is compatible with any 5-, 6- or 8-color STR analysis chemistry Madison, WI USA. -- Forensics laboratories performing human identification in criminal casework and database cases have a new option for a capillary electrophoresis (CE) instrument to support their workflow. The Spectrum CE System, launched today by Promega, presents a new alternative in [...]
INDIGO Biosciences Offers New Assay to Test Development and Oncology Therapeutics
May 17, 2022
INDIGO Offers Human Estrogen-related Receptor Beta Assay as a Commercial Assay for the First Time State College, PA – INDIGO Biosciences, the recognized industry leader in nuclear receptor reporter assays, announced today the expanding of their robust preclinical testing portfolio of cell-based reporter assays to include the Human Estrogen-related Receptor Beta (NR3B2; ERRβ). This cell-based in vitro reporter assay provides [...]
PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing
May 16, 2022
Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass. -- PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company’s portfolio of [...]
Aldevron Licenses the Manufacturing of a TYPE-V CRISPR Nuclease From Inscripta
May 16, 2022
A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, along with Inscripta®, a life science technology company dedicated to making CRISPR-based genome engineering accessible to any research lab, [...]
May 13, 2022
Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Seattle Children’s Hospital, to gain greater genomic insights into clinically relevant variants by providing accurate, affordable, scalable and comprehensive information Uncovering new discoveries across the genome Oxford Nanopore sequencing technology is to be used by a group [...]

